AIMRENY Trademark

Trademark Overview

On Friday, October 9, 2020, a trademark application was filed for AIMRENY with the United States Patent and Trademark Office. The USPTO has given the AIMRENY trademark a serial number of 90245023. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 15, 2024. This trademark is owned by Ardelyx, Inc.. The AIMRENY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of hyperphosphatemia
aimreny

General Information

Serial Number90245023
Word MarkAIMRENY
Filing DateFriday, October 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of hyperphosphatemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArdelyx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameArdelyx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFremont, CA 94555

Trademark Events

Event DateEvent Description
Tuesday, January 16, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 15, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, June 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 14, 2023SOU EXTENSION 4 GRANTED
Wednesday, June 14, 2023SOU EXTENSION 4 FILED
Wednesday, June 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, January 24, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 24, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, November 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 3, 2022SOU EXTENSION 3 GRANTED
Thursday, November 3, 2022SOU EXTENSION 3 FILED
Thursday, November 3, 2022SOU TEAS EXTENSION RECEIVED
Thursday, April 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 26, 2022SOU EXTENSION 2 GRANTED
Tuesday, April 26, 2022SOU EXTENSION 2 FILED
Tuesday, April 26, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 29, 2021SOU EXTENSION 1 GRANTED
Friday, October 29, 2021SOU EXTENSION 1 FILED
Friday, October 29, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 15, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 9, 2021ASSIGNED TO EXAMINER
Thursday, February 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 18, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 18, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 13, 2020NEW APPLICATION ENTERED

Related Keywords

aimreny hyperphosphatemia prevention treatment preparations pharmaceutical